Condition: Ischemic Stroke, Acute · Sponsor: Hospital Moinhos de Vento
A phase III, randomized, multi-center clinical trial that will examine whether treatment with intravenous TNK is superior to placebo in patients who suffer a non-large vessel occlusion ischemic stroke within 4.5-12 hours from time last seen well. The randomization employs a 1:1 ratio of intravenous thrombolysis with Tenecteplase (TNK) versus placebo in patients who suffer a non-large vessel occlusion ischemic stroke between 4.5 and 12 hours from time last seen well (TLSW) and with a clinical-radiological mismatch or evidence of salvageable brain tissue on perfusion imaging.
This description comes directly from the study's public registry record.
Gisele Sampaio Silva, MD, MPH, PhD · 5511983580583 · giselesampaio@hotmail.com
Leonardo Carbonera, MD, MsC · 555135378195 · leonardo.carbonera@hmv.org.br
Always discuss trial participation with your own doctor first.
| Hospital Moinhos de Vento | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Hospital das Clínicas Botucatu | Botucatu, Brazil | Recruiting |
| Hospital das Clínicas - UNICAMP | Campinas, Brazil | Recruiting |
| Hospital Universitário Maria Aparecida Pedrossian | Campo Grande, Brazil | Recruiting |
| Hospital das Clínicas UFPR | Curitiba, Brazil | Recruiting |
| Hospital Geral de Fortaleza | Fortaleza, Brazil | Recruiting |
| Clinica Neurologica e Neurocirurgica de Joinville | Joinville, Brazil | Recruiting |
| Hospital Metropolitano de Maceió | Maceió, Brazil | Recruiting |
| Hospital de Clínicas de Porto Alegre | Porto Alegre, Brazil | Recruiting |
| Hospital de Clínicas de Porto Alegre | Porto Alegre, Brazil | Recruiting |
| Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo | Ribeirão Preto, Brazil | Recruiting |
| Hospital de Base São José do Rio Preto | São José do Rio Preto, Brazil | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05199662